伴骨侵犯的表浅脑膜瘤:手术策略与临床结局
单中心回顾性队列研究纳入2011至2022年手术治疗的577例表浅脑膜瘤,其中47例(8.1%)存在骨侵犯。骨侵犯组复发6例(12.7%),非骨侵犯组复发48例(9.1%),两组复发率无显著差异(P=0.426),中位复发时间亦无显著差异(P=0.638)。结论认为伴骨侵犯的表浅脑膜瘤结局与无骨侵犯者相似,WHO I级脑膜瘤的骨质增生可能并非侵袭性行为的替代指标。
要点
- 577例手术治疗的table浅脑膜瘤中47例(8.1%)存在骨侵犯。
- 骨侵犯组复发6例(12.7%),非骨侵犯组复发48例(9.1%),P=0.426。
- 两组中位复发时间无显著差异(69.8个月 vs 69.7个月,P=0.638)。
核心结论
- 伴骨侵犯的表浅脑膜瘤与无骨侵犯的表浅脑膜瘤结局相似。
- WHO I级脑膜瘤的骨质增生可能并非侵袭性肿瘤行为的替代指标。
研究设计与样本
- 单中心回顾性队列研究,纳入2011年至2022年间接受手术治疗的table浅脑膜瘤患者。
- 共577例table浅脑膜瘤接受手术治疗,其中47例(8.1%)存在骨侵犯。
- 回顾年龄、性别、术前影像、手术数据和手术结局,比较骨侵犯与非骨侵犯患者的影像学变量和结局,并进行单因素分析。
主要发现
- 骨侵犯组中大多数为矢状窦旁脑膜瘤(n=29,61.7%)。
- 骨侵犯组复发6例(12.7%),非骨侵犯组复发48例(9.1%),P=0.426。
- 骨侵犯组中位复发时间69.8个月(Q1:53.1;Q3:81.4个月),非骨侵犯组69.7个月(Q1:47.5;Q3:96.7个月),P=0.638。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Meningiomas with bone involvement account for 4.5-17% of all intracranial meningiomas. Little is known about whether these meningiomas (WHO grade I) behave differently than meningiomas without bone involvement. We sought to study the relatively uncommon imaging manifestations of meningioma and to evaluate their clinical significance. METHODS: A single-institution retrospective cohort study of surgically treated superficial meningioma patients between 2011 and 2022 was conducted. Age, sex, preoperative imaging, operative data, and surgical outcomes were reviewed. Imaging variables and outcomes were reported for patients with bone-invading meningiomas and compared with those with nonbone-invading meningiomas. Univariate analyses were also conducted. RESULTS: Of 577 total superficial meningiomas treated surgically, 47 (8.1%) exhibited bone invasion. Most bone-invading meningiomas were parasagittal (n = 29, 61.7%). A total of 12.7% (n = 6) of patients with bone-invading meningioma had recurrence, whereas 9.1% (n = 48) of patients with non-bone-invading meningioma had recurrence (p = 0.426). No significant difference in the median time to recurrence was observed between patients with bone-invading meningiomas and patients with nonbone-invading meningiomas (69.8 months, Q1:53.1; Q3:81.4 months vs. 69.7 months, Q1:47.5; Q3:96.7; p = 0.638). CONCLUSIONS: Superficial meningioma with bone involvement had similar outcomes compared to those of superficial meningioma without bone involvement. Hyperostosis in meningioma (WHO grade I) may not be a surrogate for aggressive meningioma behavior.
引用
- Li G, Tian Q, Wang S, et al. Superficial meningioma with bone involvement: surgical strategies and clinical outcomes. J Neurooncol. 2024. PMID: 38689116. doi:10.1007/s11060-024-04604-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。